canagliflozin/metformin (Invokamet)

From Aaushi
Jump to navigation Jump to search

Indications

Adverse effects

More general terms

Components

References

  1. FDA Safety Alert. 09/10/2015 Invokana and Invokamet (canagliflozin): Drug Safety Communication
    New Information on Bone Fracture Risk and Decreased Bone Mineral Density. http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm461876.htm